News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
432,625 Results
Type
Article (17991)
Company Profile (79)
Press Release (414555)
Multimedia
Podcasts (12)
Webinars (8)
Section
Business (126847)
Career Advice (845)
Deals (21947)
Drug Delivery (56)
Drug Development (43462)
Employer Resources (61)
FDA (11104)
Job Trends (8452)
News (206135)
Policy (17255)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1577)
Accelerated approval (12)
Adcomms (13)
Allergies (78)
Alliances (31039)
ALS (98)
Alzheimer's disease (993)
Antibody-drug conjugate (ADC) (145)
Approvals (11388)
Artificial intelligence (319)
Autoimmune disease (109)
Automation (32)
Bankruptcy (158)
Best Places to Work (7064)
BIOSECURE Act (4)
Biosimilars (99)
Biotechnology (61)
Bladder cancer (102)
Brain cancer (35)
Breast cancer (360)
Cancer (2869)
Cardiovascular disease (187)
Career advice (719)
Career pathing (14)
CAR-T (197)
CDC (10)
Cell therapy (489)
Cervical cancer (19)
Clinical research (37524)
Collaboration (980)
Compensation (494)
Complete response letters (18)
COVID-19 (1399)
CRISPR (66)
C-suite (528)
Cystic fibrosis (69)
Data (3881)
Decentralized trials (2)
Denatured (8)
Depression (71)
Diabetes (276)
Diagnostics (4362)
Digital health (30)
Diversity (4)
Diversity, equity & inclusion (21)
Drug discovery (132)
Drug pricing (70)
Drug shortages (7)
Duchenne muscular dystrophy (87)
Earnings (56823)
Editorial (20)
Employer branding (7)
Employer resources (61)
Events (67454)
Executive appointments (623)
FDA (13190)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (824)
Gene editing (129)
Generative AI (26)
Gene therapy (328)
GLP-1 (363)
Government (2062)
Grass and pollen (2)
Guidances (297)
Healthcare (11826)
HIV (28)
Huntington's disease (18)
IgA nephropathy (42)
Immunology and inflammation (131)
Immuno-oncology (27)
Indications (68)
Infectious disease (1528)
Inflammatory bowel disease (103)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (139)
Interviews (104)
IPO (10620)
IRA (16)
Job creations (1653)
Job search strategy (634)
JPM (18)
Kidney cancer (13)
Labor market (15)
Layoffs (185)
Leadership (12)
Legal (3781)
Liver cancer (60)
Longevity (9)
Lung cancer (364)
Lymphoma (268)
Machine learning (24)
Management (22)
Manufacturing (423)
MASH (98)
Medical device (10987)
Medtech (11025)
Mergers & acquisitions (11999)
Metabolic disorders (576)
Multiple sclerosis (126)
NASH (9)
Neurodegenerative disease (179)
Neuropsychiatric disorders (45)
Neuroscience (1758)
Neurotech (1)
NextGen: Class of 2026 (3860)
Non-profit (2112)
Now hiring (15)
Obesity (190)
Opinion (134)
Ovarian cancer (98)
Pain (128)
Pancreatic cancer (140)
Parkinson's disease (152)
Partnered (19)
Patents (283)
Patient recruitment (285)
Peanut (40)
People (37165)
Pharmaceutical (18)
Pharmacy benefit managers (17)
Phase 1 (11780)
Phase 2 (16220)
Phase 3 (12715)
Pipeline (3605)
Policy (91)
Postmarket research (1289)
Preclinical (4991)
Press Release (68)
Prostate cancer (135)
Psychedelics (13)
Radiopharmaceuticals (161)
Rare diseases (435)
Real estate (3181)
Recruiting (21)
Regulatory (13914)
Reports (23)
Research institute (1486)
Resumes & cover letters (141)
Rett syndrome (22)
RNA editing (6)
RSV (39)
Schizophrenia (102)
Series A (134)
Series B (115)
Service/supplier (4)
Sickle cell disease (40)
Special edition (5)
Spinal muscular atrophy (88)
Sponsored (29)
Startups (2023)
State (1)
Stomach cancer (8)
Supply chain (47)
Tariffs (18)
The Weekly (4)
Vaccines (461)
Venture capital (34)
Weight loss (93)
Women's health (43)
Worklife (2)
Date
Today (5)
Last 7 days (346)
Last 30 days (1345)
Last 365 days (18327)
2026 (1711)
2025 (18579)
2024 (21896)
2023 (25328)
2022 (33727)
2021 (36030)
2020 (34842)
2019 (28521)
2018 (21513)
2017 (20097)
2016 (18846)
2015 (22949)
2014 (17395)
2013 (14145)
2012 (15428)
2011 (16163)
2010 (14951)
Location
Africa (380)
Alabama (36)
Alaska (3)
Arizona (207)
Arkansas (10)
Asia (23260)
Australia (3479)
California (6691)
Canada (1951)
China (570)
Colorado (295)
Connecticut (327)
Delaware (201)
Europe (53244)
Florida (1115)
Georgia (193)
Hawaii (1)
Idaho (42)
Illinois (460)
India (42)
Indiana (331)
Iowa (13)
Japan (299)
Kansas (60)
Kentucky (27)
Louisiana (18)
Maine (67)
Maryland (807)
Massachusetts (4948)
Michigan (218)
Minnesota (471)
Mississippi (4)
Missouri (91)
Montana (32)
Nebraska (16)
Nevada (80)
New Hampshire (53)
New Jersey (1997)
New Mexico (19)
New York (1846)
North Carolina (875)
North Dakota (8)
Northern California (3358)
Ohio (227)
Oklahoma (12)
Oregon (22)
Pennsylvania (1187)
Puerto Rico (11)
Rhode Island (30)
South America (559)
South Carolina (43)
South Dakota (1)
Southern California (2519)
Tennessee (105)
Texas (1156)
United States (24514)
Utah (221)
Vermont (1)
Virginia (144)
Washington D.C. (30)
Washington State (590)
West Virginia (2)
Wisconsin (78)
Wyoming (1)
432,625 Results for "mts systems corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myosin Therapeutics Receives FDA Fast Track Designation for MT-125 in Glioblastoma
October 22, 2025
·
2 min read
Press Releases
CREATE Medicines Doses First Patient in Frontline HCC Trial Evaluating MT-303, an In Vivo CAR Therapy, in Combination with Standard-of-Care Immunotherapy
December 10, 2025
·
5 min read
Press Releases
T-MAXIMUM Pharmaceutical’s Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma
December 22, 2025
·
4 min read
Press Releases
CREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
November 4, 2025
·
2 min read
Press Releases
Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting
November 4, 2025
·
7 min read
Press Releases
Neurona Expands Investigation of NRTX-1001 Cell Therapy into Mesial Temporal Lobe Epilepsy (MTLE) without Mesial Temporal Sclerosis (MTS)
October 7, 2025
·
5 min read
Press Releases
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
August 19, 2025
·
2 min read
Press Releases
Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system
Several recent steps move the closure toward commercialization: · New studies confirm the system’s usability and performance · Design now finalized and preparations for industrialization underway · Multiple new features set a new standard for luer lock closure systems
January 15, 2026
·
1 min read
Press Releases
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
January 5, 2026
·
9 min read
Press Releases
4M Therapeutics Reports Positive Results from 4MT2001 GLP Safety Studies
June 11, 2025
·
2 min read
1 of 43,263
Next
